Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is an autoimmune disorder causing hair loss and can impact mental health.

Dermatologists should focus on restoring skin health and well-being in cancer survivors.

The document concludes that hair loss has many causes and treatments vary, including medication for pattern baldness and addressing underlying issues for other types.

Targeted therapies for advanced skin cancer often cause hair and nail problems, which need managing to avoid changing the treatment dose.

Switching immunosuppressants can improve hair regrowth and well-being in transplant patients experiencing hair loss.

Alopecia areata requires addressing both emotional and financial challenges for better patient care.

Children's books on alopecia and trichotillomania often miss important treatment information.

Understanding both skin and mental health aspects of alopecia areata is crucial for better patient care.

Psychological factors significantly impact alopecia areata.

Most postmenopausal women experience skin and hair issues, so regular check-ups are important.

The document suggests managing female pattern hair loss by checking and correcting B12, folate, and thyroid levels, and considering an androgen profile if there are signs of excess androgen.

Patients with schizophrenia have a high rate of skin diseases, with fungal infections and dermatitis being most common, and those on clozapine have a lower risk of fungal infections.

Breast cancer patients should balance treatment with safe wellness practices to improve quality of life, consulting their oncologist first.

A girl with Crohn's disease developed hair loss from her medication, which improved with treatment but later returned.

Alopecia areata causes significant psychological distress in cancer patients, needing integrated care.

Scalp cooling is cost-effective for reducing hair loss from chemotherapy and should be covered by insurance.

Eyebrow mesotherapy improves eyebrow appearance and boosts confidence and mood.

The document provides guidelines for effective and safe treatments for hair loss in men and women.

Cord blood platelets may have promising future medical uses but need more research.

Cri-du-chat syndrome can cause skin and oral lesions affecting nutrition and quality of life.

Switching immunosuppressive drugs can improve hair regrowth and well-being in transplant patients with hair loss.

Hair loss from immunosuppressive drugs in transplant patients can affect well-being and treatment adherence, so personalized management is important.

The model accurately predicts hair breakage in Telogen Effluvium, aiding early detection and treatment.

Critical illness can lead to long-lasting physical and psychological problems, requiring ongoing, specialized care and rehabilitation.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

European guidelines recommend regular eye and ear exams, skin care, vitamin D supplements, and cautious use of medications for managing congenital ichthyoses.

Targeted anticancer therapies often cause skin issues, affecting treatment adherence and quality of life.

Nurses are crucial in managing chemotherapy side effects for ovarian cancer patients to improve their quality of life.

Many patients with various medical conditions experience anxiety, which worsens their quality of life and raises healthcare costs.

Hair disorders significantly affect self-image, mental health, and quality of life.